Search

everythinglearnresearchcommunity

for

Search:↓

Inhibiting TYK2 can restore hair growth in alopecia areata.

Upadacitinib successfully regrew hair in a child with alopecia universalis and specific genetic mutations.

Ritlecitinib is cost-effective for severe alopecia areata in Japan.

Baricitinib helps treat several diseases, including COVID-19, but has side effects and needs careful monitoring.

Akt2 protein is essential for normal cell division in early mouse embryos.

Ruxolitinib reduced inflammation and improved symptoms in APECED patients but may cause anemia and weight gain.

Erlotinib causes skin inflammation through IL-1, which can be reduced by anakinra.

Radiation therapy with a higher dose for the brain improves survival in cerebellar medulloblastoma.

Lymphoid-specific helicase (Lsh) is crucial for skin growth, change, and healing after injury.

ADM hydrogels help heal radiation skin injuries.

Ritlecitinib effectively reduces severe hair loss in alopecia areata over 24 months.

LRIG1 is linked to better survival in Merkel cell carcinoma.

Ruxolitinib significantly improves multiple autoimmune conditions in APS-1 patients.

Ritlecitinib effectively promotes hair regrowth in alopecia areata patients, even with extensive hair loss.

SII is a useful and affordable tool to assess and monitor alopecia areata.

The study found that a one-step antibody method is better than the LSAB method for accurately studying hair follicle structures without false positives.

Tislelizumab can cause cutaneous lupus erythematosus.

Ritlecitinib helps reduce inflammation and promote hair regrowth in alopecia areata, especially in patchy-type cases.

Ark-e-Kasni improves PCOS symptoms and may be a potential treatment.

Fractional CO2 laser therapy effectively improves skin conditions and recovery when combined with other treatments.

Innate lymphoid cells type 1 may contribute to alopecia areata by damaging hair follicles.

Ritlecitinib improves emotional well-being and activity levels in alopecia areata patients.

Upadacitinib may effectively treat resistant lichen planopilaris.

Ritlecitinib helps regrow hair in alopecia areata and is safe for long-term use.

pbn-STAC effectively finds strategies for cellular reprogramming using deep reinforcement learning.

RC48 shows promise for treating certain advanced cancers, but more research is needed.

The laser system can safely improve recovery and quality of life for cervical cancer patients after surgery.

IL-36α helps in growing new hair follicles when healing wounds, potentially aiding in hair growth.

Optical imaging and light therapy show promise for diagnosing and treating liver injury caused by surgery.